p-Trifluoromethyl- and p-pentafluorothio-substituted curcuminoids of the 2,6-di[(E)-benzylidene)]cycloalkanone type: Syntheses and activities against Leishmania major and Toxoplasma gondii parasites.
A series of the title curcuminoids with structural variance in the heteroatom of the cycloalkanone and the p-substituents of the phenyl rings were tested for their activities against Leishmania major and Toxoplasma gondii parasites. The majority of them showed high activities against both parasite forms with EC50 values in the sub-micromolar concentration range. Bis(p-pentafluorothio)-substituted 3,5-di[(E)-benzylidene]piperidin-4-one 1b was not just noticeable antiparasitic, but also exhibited a considerable selectivity for L. major promastigotes over normal Vero cells. While derivatives differing only in the p-phenyl substituents being CF3 or SF5 showed similar antiparasitic activities, the cyclic ketone hub was more decisive both for the anti-parasitic activities and the selectivities for the parasites vs. normal cells. QSAR calculations confirmed the observed structure-activity relations and suggested structural variations for a further improvement of the antiparasitic activity. Docking studies based on DFT calculations revealed L. major pteridine reductase 1 as a likely molecular target protein of the title compounds.
['Al Nasr|Ibrahim S|IS|', 'Hanachi|Riadh|R|', 'Said|Ridha B|RB|', 'Rahali|Seyfeddine|S|', 'Tangour|Bahoueddine|B|', 'Abdelwahab|Siddig I|SI|', 'Farasani|Abdullah|A|', 'M E Taha|Manal|M|', 'Bidwai|Anil|A|', 'Koko|Waleed S|WS|', 'Khan|Tariq A|TA|', 'Schobert|Rainer|R|', 'Biersack|Bernhard|B|']
Anti-parasitic drugs Curcumin Fluorine Neglected tropical diseases